1. Home
  2. MOGO vs INKT Comparison

MOGO vs INKT Comparison

Compare MOGO & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mogo Inc.

MOGO

Mogo Inc.

HOLD

Current Price

$1.13

Market Cap

27.6M

Sector

N/A

ML Signal

HOLD

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

HOLD

Current Price

$12.27

Market Cap

51.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOGO
INKT
Founded
2003
2017
Country
Canada
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.6M
51.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MOGO
INKT
Price
$1.13
$12.27
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$4.00
$35.00
AVG Volume (30 Days)
102.8K
19.4K
Earning Date
11-07-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.22
N/A
Revenue
$29,215,516.00
N/A
Revenue This Year
$63.05
N/A
Revenue Next Year
$5.58
N/A
P/E Ratio
$5.07
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.74
$4.56
52 Week High
$3.83
$76.00

Technical Indicators

Market Signals
Indicator
MOGO
INKT
Relative Strength Index (RSI) 37.66 46.02
Support Level $1.09 $10.99
Resistance Level $1.16 $12.68
Average True Range (ATR) 0.05 0.85
MACD 0.01 0.06
Stochastic Oscillator 25.00 42.40

Price Performance

Historical Comparison
MOGO
INKT

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established world-wide corporations and fintech companies in Europe and Canada.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Share on Social Networks: